Brand
Bezalip, Bezalip Retard, Cholecaps.
How it Works
Bezafibrate is a medication widely used to reduce high cholesterol and harmful fat levels in the blood (hyperlipidemia). It works by stimulating the enzyme triglyceride lipase, which plays a role in breaking down cholesterol and fat. This process lowers bad cholesterol (LDL) while increasing good cholesterol (HDL) in the bloodstream.
Indications
Bezafibrate is prescribed for medical conditions such as hyperlipidemia (elevated cholesterol or high levels of unhealthy fats in the blood).
Contraindications
Bezafibrate should not be used in patients with:
-
A history of hypersensitivity or allergy to bezafibrate
-
Gallbladder disease
-
Low albumin protein levels in the blood (hypoalbuminemia)
-
Severe liver or kidney disorders
-
Pregnancy or breastfeeding
Side Effects
Although side effects are uncommon, some patients may experience:
-
Loss of appetite
-
Nausea or vomiting
-
Headache
-
Dizziness
-
Weakness
-
Skin reactions such as red spots, itching, or hives
-
Impotence
-
Anemia
-
Abdominal pain
-
Depression
-
Insomnia
-
Constipation
-
Diarrhea
-
Muscle pain
-
Acute kidney failure
-
Rare but serious skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis
Types
Bezafibrate is available in the following forms:
-
200 mg film-coated tablets
-
400 mg tablets
-
200 mg capsules
Dosage
Purpose: to treat hyperlipidemia
Adults dosage: 200 mg three times daily.
Depending on gastrointestinal tolerance, the dose may be adjusted after 5–7 days to a maintenance dose of 200 mg twice daily. Tablets should be taken immediately after meals.
Safety
Pregnancy:
Bezafibrate is classified as FDA Category N, meaning its potential effects on the fetus are not yet fully known. Pregnant women should only take this medicine under medical supervision.
Drug Interactions
Cholestyramine
When taken together with cholestyramine, bezafibrate absorption in the digestive tract may be reduced, lowering its effectiveness. If both drugs are prescribed, they must be taken under close medical monitoring.
Looking for more information about other drugs? Click here!
- dr Hanifa Rahma
Badan Pengawas Obat dan Makanan. Bezafibrat. Available from: https://pionas.pom.go.id/monografi/bezafibrat
Mims Indonesia. Bezafibrate. Available from: https://www.mims.com/indonesia/drug/info/bezafibrate?mtype=generic
Medscape. Bezafibrate. Available from: https://www.medscape.com/viewarticle/786941